Clinical Trials in Tartu, Tartu
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC868 enrolled226 locationsNCT06077760
Recruiting
Phase 3
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms
Merck Sharp & Dohme LLC1,314 enrolled320 locationsNCT06136650
Recruiting
Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients
Chronic Kidney Disease Requiring Chronic Dialysis
University of Tartu30 enrolled1 locationNCT06873880
Recruiting
Not Applicable
Kinesiophobia After Anterior Cruciate Ligament Reconstruction.
KinesiophobiaACL Injury
Tartu University Hospital144 enrolled1 locationNCT05762809